Gujarat-based pharmaceutical manufacturer selling branded human and veterinary formulations in India and select export markets.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 29 | 29 | 29 | 31 | 33 | 36 | 36 | 36 |
| Reserves | -43 | -54 | -15 | 15 | 35 | 69 | 65 | 57 |
| Borrowings | 141 | 163 | 130 | 75 | 59 | 39 | 32 | 49 |
| Other Liabilities | 73 | 52 | 42 | 31 | 30 | 32 | 35 | 33 |
| Total Liabilities | 200 | 190 | 186 | 152 | 157 | 176 | 168 | 175 |
| AssetsFixed Assets | 105 | 98 | 94 | 68 | 58 | 85 | 87 | 87 |
| CWIP | 28 | 26 | 18 | 16 | 23 | 1 | 1 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 68 | 66 | 74 | 67 | 76 | 90 | 80 | 86 |
| Total Assets | 200 | 190 | 186 | 152 | 157 | 176 | 168 | 175 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 27 | 5 | 9 | 79 | 9 | 2 | 2 | 5 |
| Cash from Investing | -4 | 0 | 0 | -6 | 7 | -9 | -12 | -9 |
| Cash from Financing | -23 | 3 | -12 | -63 | -22 | 2 | 5 | 4 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 23 | 4 | 8 | 72 | 15 | -7 | -10 | -6 |
| FCF Margin | — | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
LYKALABS · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.